ARK Genomic Revolution ETF (BATS:ARKG) Hits New 12-Month High – Time to Buy?

ARK Genomic Revolution ETF (BATS:ARKG) shares hit a new 52-week high on Monday . The company traded as high as $44.53 and last traded at $44.44, with a volume of 1245037 shares trading hands. The stock had previously closed at $43.04.

ARK Genomic Revolution ETF Stock Up 0.5%

The firm’s fifty day moving average price is $38.96 and its 200 day moving average price is $32.65.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in ARKG. NewEdge Advisors LLC grew its stake in shares of ARK Genomic Revolution ETF by 49.4% in the first quarter. NewEdge Advisors LLC now owns 5,384 shares of the company’s stock valued at $112,000 after buying an additional 1,780 shares in the last quarter. Creative Planning purchased a new position in ARK Genomic Revolution ETF during the 2nd quarter valued at about $255,000. Baird Financial Group Inc. boosted its holdings in ARK Genomic Revolution ETF by 81.0% during the 2nd quarter. Baird Financial Group Inc. now owns 71,977 shares of the company’s stock valued at $1,753,000 after acquiring an additional 32,221 shares during the period. Strategic Wealth Investment Group LLC acquired a new position in ARK Genomic Revolution ETF in the 2nd quarter valued at about $38,000. Finally, Group One Trading LLC purchased a new stake in ARK Genomic Revolution ETF during the second quarter worth about $2,274,000.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.